ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 85 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $512 | -38.3% | 525 | 0.0% | 0.00% | – |
| Q1 2024 | $830 | +99.0% | 525 | 0.0% | 0.00% | – |
| Q4 2023 | $417 | +1.7% | 525 | 0.0% | 0.00% | – |
| Q3 2023 | $410 | -15.6% | 525 | 0.0% | 0.00% | – |
| Q2 2023 | $486 | -15.2% | 525 | 0.0% | 0.00% | – |
| Q1 2023 | $573 | -25.2% | 525 | 0.0% | 0.00% | – |
| Q4 2022 | $766 | -23.4% | 525 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 525 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 525 | +50.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 350 | +66.7% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 210 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,000 | 0.0% | 210 | +75.0% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,000 | – | 120 | +200.0% | 0.00% | – |
| Q3 2020 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $4,405,481 | 2.16% |
| MPM BioImpact LLC | 5,095,912 | $4,041,058 | 0.94% |
| NEA Management Company, LLC | 17,079,778 | $13,544,624 | 0.90% |
| Syncona Portfolio Ltd | 1,377,294 | $1,092,194 | 0.69% |
| PFM Health Sciences, LP | 10,423,135 | $8,265,546 | 0.50% |
| TANG CAPITAL MANAGEMENT LLC | 4,387,238 | $3,479,080 | 0.32% |
| Long Focus Capital Management, LLC | 12,086,915 | $9,584,924 | 0.32% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,906,529 | 0.32% |
| Acuitas Investments, LLC | 479,789 | $380,473 | 0.20% |
| Key Client Fiduciary Advisors, LLC | 336,620 | $266,940 | 0.16% |